Research map: Elevated Lipoprotein (a) and Large Apo(a) Isoforms in Omani Patients: a Distinct Cardiovascular Risk Profile

Back to the article

Papers in this map

  1. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement · Florian Kronenberg · 2022 · 1455 citations · Cited by this paper
  2. Impact of High-sensitivity C-reactive protein testing on statin use in primary prevention: A national multicenter analysis · 2026 · Related
  3. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease · Aniruddh P. Patel · 2020 · 558 citations · Cited by this paper
  4. Association of reproductive factors with acute myocardial infarction in young women: A VIRGO and NHANES case-control study · 2026 · Related
  5. PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability · Byambaa Enkhmaa · 2020 · 15 citations · Cited by this paper
  6. Incretin therapy prescription in a high cardiovascular risk population: Insights from a cardiology-based cardiometabolic program · 2026 · Related
  7. Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk · Stefan Coassin · 2022 · 11 citations · Cited by this paper
  8. Beyond place: Neighborhood deprivation, cardiometabolic health, and the life course origins of hypertensive disorders of pregnancy · 2026 · Related
  9. Cardiovascular Implications of Lipoprotein(a) and its Genetic Variants · Ayman Ahmed El-Menyar · 2025 · 8 citations · Cited by this paper
  10. Absence of significant coronary artery disease does not eliminate smoking-related cardiovascular risk: insights from the PROMISE trial · 2026 · Related
  11. Don’t sleep on the other beds: Atherosclerosis across heart, brain, and limbs · 2026 · Related
  12. Prevalence and predictors of silent atherosclerosis across life: Design of the REACT Phase 1 study · 2026 · Related
  13. Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center · 2026 · Related
  14. Effectiveness of Yoga-based guided meditation In Improving the quality of sleep in patients with coronary artery disease: The Yoga Nidra Trial · 2026 · Related
  15. The Coverage Gap in PREVENT: Why Cardiovascular Risk Prediction Needs a Lab-Free Complement · 2026 · Related

Source: OpenAlex (CC0)